Salix Pharmaceuticals pays $60m up front for constipation drug Relistor
Salix Pharmaceuticals, which focuses on gastrointestinal treatments, is paying $60 million to license constipation drug Relistor from Progenics Pharmaceuticals. Morrisville, North Carolina-based Salix could pay up to $90 million in additional milestone payments if the company is able to hit regulatory milestones.